BIOFILCHEM vs VIYASH: Stock Comparison

BIOFIL CHEM & PHARMA vs VIYASH SCIENTIFICUpdated 11 Sept 26, 4:08 PM ISTNSE & company filings

VIYASH SCIENTIFIC is the larger company by market capitalisation. BIOFIL CHEM & PHARMA shows a higher ROE, a higher ROCE and a higher net margin, while VIYASH SCIENTIFIC shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

BIOFILCHEM leads 5; VIYASH leads 4 of 11

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

BIOFILCHEMVIYASH

Valuation lens

What price are you paying?

Market CapContext only
₹56 Cr
₹11,228 Cr
P/E RatioSame reading
61.63x
P/B RatioSame reading
3.86x
EPSVIYASH has the higher reading
₹0.07
₹1.51
Book ValueContext only
₹13.25
₹71.3
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
VIYASH is the larger company
₹11,228 Cr vs ₹56 Cr
EPS
VIYASH has higher earnings per share
₹1.51 vs ₹0.07
Revenue Growth (TTM YoY)
VIYASH has faster revenue growth
0% vs -9.3%
EPS Growth (TTM YoY)
BIOFILCHEM has faster EPS growth
10.8% vs 0%
Qtr Sales Growth
VIYASH has stronger quarterly sales growth
167.57% vs -56.51%
Qtr Profit Growth
VIYASH has stronger quarterly profit growth
279.02% vs -96.08%
ROE
BIOFILCHEM has a higher ROE
12.92% vs 4.88%
ROCE
BIOFILCHEM has a higher ROCE
11.39% vs 4.99%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBIOFILCHEMVIYASH
SectorHealthcare
IndustryPharmaceuticals

Price

MetricBIOFILCHEMVIYASH
Live Price₹34.51₹257.6
Day Change-6.2%-1.09%
Volume1.73 L18.6 L
52-Week High₹46.34₹298
52-Week Low₹25.6₹178.13
Distance from 52W High-25.53%-13.56%

Valuation

MetricBIOFILCHEMVIYASH
Market Cap₹56 Cr₹11,228 Cr
P/E Ratio61.63x
P/B Ratio3.86x
EPS₹0.07₹1.51
Book Value₹13.25₹71.3
Dividend Yield0%0%

Growth

MetricBIOFILCHEMVIYASH
Revenue Growth (TTM YoY)-9.3%0%
EPS Growth (TTM YoY)10.8%0%
Qtr Sales Growth-56.51%167.57%
Qtr Profit Growth-96.08%279.02%

Profitability & Leverage

MetricBIOFILCHEMVIYASH
ROE12.92%4.88%
ROCE11.39%4.99%
Net Margin9.81%6.57%
Operating Margin12.18%11.72%
Debt to Equity0.14x0.14x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBIOFILCHEMVIYASH
Promoter Holding46.79%0%
FII Holding0%4.5% 1.56 pp
DII Holding0.08%3.75% 4.24 pp
Public Holding53.13%30.34% 2.67 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BIOFIL CHEM & PHARMA and VIYASH SCIENTIFIC.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.